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ABSTRACT After damage, cells reseal their plasma membrane and repair the underlying 
cortical cytoskeleton. Although many different proteins have been implicated in cell repair, 
the potential role of specific lipids has not been explored. Here we report that cell damage 
elicits rapid formation of spatially organized lipid domains around the damage site, with dif-
ferent lipids concentrated in different domains as a result of both de novo synthesis and 
transport. One of these lipids—diacylglycerol (DAG)—rapidly accumulates in a broad domain 
that overlaps the zones of active Rho and Cdc42, GTPases that regulate repair of the cortical 
cytoskeleton. Formation of the DAG domain is required for Cdc42 and Rho activation and 
healing. Two DAG targets, protein kinase C (PKC) β and η, are recruited to cell wounds and 
play mutually antagonistic roles in the healing process: PKCβ participates in Rho and Cdc42 
activation, whereas PKCη inhibits Rho and Cdc42 activation. The results reveal an unexpect-
ed diversity in subcellular lipid domains and the importance of such domains for a basic cel-
lular process.
INTRODUCTION
One of the most fascinating and important features of eukaryotic 
cells is their ability to rapidly polarize in response to intrinsic or ex-
trinsic signals. This polarization is often first manifest at the plasma 
membrane, where different proteins are recruited as cells are ex-
posed to local stimuli such as growth factors, cell–cell contact, or 
progression through the cell cycle. Such polarization is universal and 
underlies an enormous number of fundamental biological processes 
(Mellman and Nelson, 2008).
Cell damage represents a local stimulus, the response to which is 
both conserved and essential (Sonnemann and Bement, 2011). Cell 
repair results from two complementary processes: resealing of the 
plasma membrane (McNeil and Steinhardt, 2003) and restitution of 
the cortical cytoskeleton (Sonnemann and Bement, 2011). The im-
portance of these processes is considerable, in that excessive cell 
damage and/or compromised repair results in or is associated with 
a variety of pathologies, including the muscular dystrophies (Laval 
and Bushby, 2004), acute lung injury (Godin et al., 2011), and diabe-
tes (Howard et al., 2011).
Efforts to understand the cell damage–repair cycle have focused 
on proteins, resulting in the identification of several players that are 
needed to either limit cell damage in response to normal physical 
stresses exerted on the plasma membrane, such as dystrophin 
(Lapidos et al., 2004), or participate in the repair process, such as 
dysferlin (Bansal et al., 2003), annexin (Lennon et al., 2003; McNeil 
et al., 2006), and MG53 (Cai et al., 2009). Several proteins have also 
been implicated in cortical cytoskeleton repair, including the Rho 
GTPases Rho, Cdc42, and Rac (Benink and Bement, 2005; 
Abreu-Blanco et al., 2014), the actin regulatory protein cortactin 
(Godin et al., 2011), Abr, a guanine nucleotide exchange factor 
(GEF) and GTPase-activating protein for Rho GTPases (Vaughan 
et al., 2011), and E-cadherin (Abreu-Blanco et al., 2011). However, 
the potential role of specific lipids in cell repair has not been system-
atically explored, in spite of the fact that lipid domains participate in 
other polarization events (e.g., Takeda et al., 2004; Liu et al., 2009), 
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different lipid probes were directly compared with each other. For 
example, the DAG and PIP3 domains were circumscribed by the 
PIP2 domain (Figure 1, F and G), as expected based on their posi-
tions relative to Cdc42. However, other comparisons suggested 
even more compartmentalization. For example, PS and PA, both of 
which concentrate inside the Cdc42 zone, nevertheless display 
overlapping but distinct domains, with the peak of PA signal just 
outside the peak of the PS signal (Figure 1H). In other words, the 
region immediately next to the wound has at least two overlapping 
but also distinct domains with qualitatively different lipid composi-
tions, and these are different again from the region farther from the 
wound edge, which is enriched in PIP2. Similarly, triple labeling us-
ing fluorescent actin and different pairs of lipid probes reveals the 
existence of at least three overlapping but distinct compartments 
(Supplemental Figure S1D). Finally, even lipids that show a similar 
distribution at 90 s, such as DAG and PA (Figure 1I), behave differ-
ently at earlier time points (Figure 1, D and E), indicating a consider-
able degree of plasma membrane lipid compartmentalization.
PA and DAG are generated at the wound edge coincident 
with Rho GTPase activation
DAG and PA were the lipids most rapidly and extensively concen-
trated at wound edges (Figures 1 and 2, A and B), as might be 
expected if these lipids serve as upstream regulators of Rho and 
Cdc42. Consistent with this possibility, direct comparison of the 
recruitment patterns of DAG and PA to active Rho indicated that 
these two lipids are recruited at the same time and in the same 
place as Rho activation (Figure 2, C–C′ and D–D′). Because Rho and 
Cdc42 are activated before and independently of actomyosin-pow-
ered cortical flow after wounding (Benink and Bement, 2005), and as 
a means to distinguish between lipid accumulation at wounds via 
transport versus de novo synthesis, we assessed the relationship be-
tween the different lipids and cortical flow. Brightest-point projec-
tions demonstrated that PIP3, PIP2, and PS undergo extensive corti-
cal flow toward the wounds, whereas PA and DAG display relatively 
little cortical flow (Figure 2E), consistent with accumulation via de 
novo generation rather than transport. Further, pretreatment of cells 
with latrunculin A before wounding to disrupt cortical F-actin and 
block cortical flow failed to prevent accumulation of DAG and PA at 
wounds (Figure 2F), whereas this same treatment disrupted normal 
patterns of accumulation of the other lipids (unpublished data). 
These results are consistent with PA and DAG acting upstream of 
Rho and Cdc42 and show that these lipids accumulate around 
wounds at least in part due to wound-triggered de novo synthesis.
DAG generation occurs via the phosphatidylcholine-PLC/
sphingomyelin synthase pathway, whereas PA is generated 
via phospholipase D and DAG kinase
On the basis of the foregoing results, we assessed the potential 
sources of the fast lipids—PA and DAG. Because a given lipid is typi-
cally the output of several different pathways, and because, con-
versely, a given lipid can serve as a precursor for several other differ-
ent lipids, we used pharmacological approaches (Figure 3H). DAG is 
generated from PA via phospholipase D (PLD) and phosphatidic 
acid phosphohydrolase (PAPH), from phosphatidylinositol 4,5-bis-
phosphate via PIP2-PLC, from ceramide/phosphatidylcholine 
(PC) via sphingomyelin synthase (SMS), and from PC via PC-PLC 
(Wakelam, 1998). To determine whether PA was a source of DAG, 
we treated cells with 5-fluoro-2-indolyl des-chlorohalopemide (FIPI), 
a highly specific PLD inhibitor (Su et al., 2009). FIPI did not change 
DAG levels after wounding (Figure 3, B and B′), but it significantly 
reduced PA levels (Figure 3, E and E′), as determined by quantifying 
many of the known protein players in cell repair bind lipids, and 
plasma membrane damage necessarily entails local disruption of 
the lipid environment. Here we analyze the potential role of different 
lipids in single-cell repair in the Xenopus oocyte model. We find that 
plasma membrane damage elicits profound local changes in the 
abundance and distribution of different phospholipids, different lip-
ids sort into overlapping but spatially distinct domains around 
wounds, and at least one of the lipids studied, diacylglycerol, is es-
sential for proper wound repair.
RESULTS
Multiple lipid domains form around single-cell wounds
To explore the potential role of lipids in the repair process, we mi-
croinjected Xenopus oocytes with mRNAs encoding probes for dif-
ferent lipids and a probe for active Cdc42 (monomeric red fluores-
cent protein [mRFP]-wGBD; Figure 1, A′–E′) to serve as a spatial 
reference point, since active Cdc42 consistently localizes to a zone 
∼5 μm from the wound edge (Benink and Bement, 2005). The distri-
bution of different lipids was compared using previously described 
probes: phosphatidic acid (PA) was detected with a fragment of 
Spo20p (Zeniou-Meyer et al., 2007); diacylglycerol (DAG) was de-
tected with the C1 domain of protein kinase C (PKC) η (Dries et al., 
2007; Yu and Bement, 2007); phosphatidylinositol 3,4,5-trisphos-
phate (PIP3) was detected by GRP1 PH (Gray et al., 1999); phos-
phatidylinositol 4,5-bisphosphate (PIP2) was detected by phospho-
lipase C (PLC) δ PH (Raucher et al., 2000); and phosphatidylserine 
(PS) was detected by the C2 domain of lactadherin (Yeung et al., 
2008). Because the PA and DAG probes are less well characterized 
than those for PIP2, PIP3, and PS, the specificity of these probes was 
tested by analyzing localization of point mutants lacking either PA- 
or DAG-binding ability, respectively; such point mutants failed to 
localize to wounds (Supplemental Figure S1, B and C). To further 
ensure the specificity of the results, the distribution of farnesylated 
GFP (fGFP)—a generic marker for plasma membrane proteins—was 
followed.
Cells expressing mRFP-wGBD and the various lipid probes were 
wounded and analyzed by four-dimensional imaging to track pat-
terns of lipid distribution over time. Although each lipid ultimately 
showed a distinct spatiotemporal distribution pattern (see later dis-
cussion), the probes revealed two general patterns of lipid behavior 
based on kinetics: slow, in which the probes did not reveal changes 
in lipid distribution until after formation of the Cdc42 zone 
(∼20–40 s postwounding), and fast, in which the probes revealed 
changes in lipid distribution before or coincident with the formation 
of Cdc42 zone (∼15–20 s postwounding; Figures 1 and 2A). Slow 
behavior was displayed by PIP3, PIP2, and PS. PIP3 and PS concen-
trated just inside the active Cdc42 zone, whereas PIP2 concentrated 
outside the Cdc42 zone (Figure 1, A–A′, B–B′, and C–C′). fGFP also 
accumulated around wounds, in a region that overlapped the Cdc42 
zone; however, this was a relatively late event, and the extent of ac-
cumulation was relatively modest (Supplemental Figure S1, A–A′). 
Fast behavior was displayed by PA and DAG. PA showed the fastest 
change, undergoing depletion around wounds immediately after 
wounding (i.e., within 6 s) and then reaccumulating and concentrat-
ing predominantly inside the nascent Cdc42 zone (Figure 1, D–D′). 
DAG also concentrated predominantly inside the forming Cdc42 
zone but without undergoing an initial depletion around wounds 
(Figure 1, E–E′).
The apparent differences in distribution of the various lipid 
probes relative to active Cdc42 indicated a surprising degree of 
lipid domain diversity around wounds. This notion was further 
supported by experiments in which the dynamic distributions of 
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FIGURE 1: Multiple, distinct lipid domains form around single-cell wounds. (A) eGFP-PH (GRP1) detects PIP3 
accumulation. (A′) PIP3 peak enrichment occurs inside the active Cdc42 zone at 90 s. (B) eGFP-PH (PLCδ) detects PIP2 
enrichment. (B′) PIP2 peak enrichment is outside the active Cdc42 zone at 90 s. (C) eGFP-C2 (lactadherin) detects PS 
enrichment. (C′) PS peak enrichment occurs inside the active Cdc42 zone at 90 s. (D) eGFP-Spo20 detects a region of PA 
depletion (arrowheads) immediately after wounding, followed by enrichment. (D′) The peak of PA signal is found inside 
the zone of active Cdc42 at 90 s. (E) eGFP-C1 (PKCη) detects a region of DAG enrichment. (E′) The peak of DAG 
enrichment leads the peak of active Cdc42 at 90 s. (F) The peak of DAG enrichment leads the peak of PIP2. (G) The 
peak of PIP3 enrichment leads the peak of PIP2. (H) The peak PS signal leads the peak PA signal. (I) The peak DAG and 
PA signal are colocalized. (J) Schematic of lipid localization relative to the active Rho and Cdc42 zones. Scale bar, 20 μm. 
W, wound.
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completely eliminate wound-induced PA synthesis (Figure 3, E–E′ 
and G–G′). In contrast, treatment with FIPI resulted in near-com-
plete inhibition of PA generation after wounding (Figure 3, F–F′). 
These results suggest that PA is primarily derived from PC, with 
DAG also partially contributing to the PA enrichment zone at 
wounds.
DAG is required for Rho and Cdc42 activation
Given that PA and DAG are generated at the proper time and place 
to activate the Rho GTPases, we explored their potential role in Rho 
GTPase activation. Treatment with D609, which dramatically re-
duced DAG and modestly reduced PA at wounds (see foregoing 
discussion), strongly suppressed Cdc42 and Rho activation (Figure 
4, A–C) and led to little apparent wound closure in the first 2 min 
after wounding. These results implied that DAG, PA, or both might 
be required for Rho activation. To determine whether PA was 
fluorescence intensity in the region of the lipid domains around 
wounds (Figure 3, B–B′ and D–D′), suggesting that DAG generation 
is PA independent. Similarly, DAG generation was not dependent 
on PIP2, as treatment with the PI-PLC inhibitor U-73122 (Smith et al., 
1990) did not inhibit, but instead increased, DAG at wounds (Figure 
3, C–C′). In contrast, D609, a PC-PLC and SMS inhibitor (Amtmann, 
1996; Luberto and Hannun, 1998) significantly reduced DAG gen-
eration at the wound edge (Figure 3, A–A′), indicating that PC and/
or ceramide, rather than PA or PIP2, are sources of DAG during cell 
damage.
The two major sources of signaling PA are PC (via PLD activity) 
and DAG (via DAG kinase activity; Wang et al., 2006; Figure 3H). To 
determine the origin of PA at the wound, we treated cells with the 
PLD inhibitor FIPI, the DAG kinase inhibitor R59949 (de Chaffoy de 
Courcelles et al., 1989), or the PC-PLC and SMS inhibitor D609. 
Treatment with either D609 or R59949 reduced but did not 
FIGURE 2: PA and DAG are generated at the wound edge coincident with Rho GTPase activation. (A) Recruitment 
times for each lipid were quantified. PA appeared at 16.8 s, and DAG at 18.5 s, whereas PIP3, PIP2, and PS accumulated 
at ≥32 s (PA, n = 10; DAG, n = 12; PIP3, n = 12; PIP2, n = 8; PS, n = 8; error bars, SEM). (B) The ratio of zone/background 
fluorescence intensity was calculated for each lipid at 90 s (PA, PIP3, n = 6; DAG, PIP2, PS, n = 5; error bars, SEM). 
(C) Cells injected with mCherry-rGBD and eGFP-Spo20 were wounded. A kymograph shows corecruitment of active Rho 
and PA to the wound edge. (C′) The intensity/time plotted from a vertical line drawn through the wound edge in C. 
(D) Cells injected with eGFP-rGBD and mRFP-C1 were wounded. A kymograph shows corecruitment of active Rho and 
DAG to the wound edge. (D′) Intensity/time plotted from a vertical line drawn through the wound edge in D. 
(E) Brightest-point projections from movies show the contribution of cortical flow (indicated by lines perpendicular to 
the wound edge) to enrichment of each lipid. PA and DAG are less dependent on cortical flow than PIP3, PIP2, and PS. 
(F) Cells were treated with latrunculin A to abolish actin-mediated cortical flow, but PA and DAG still accumulated, as 
indicated by arrowheads. Scale bar, 10 μm (C, D); 20 μm (E, F).
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eukaryotic PC-PLC has been identified, precluding knockdown or 
dominant-negative approaches. We therefore tested SPK-601, a 
putative PC-PLC inhibitor (Walker, 2010). Because SPK-601 is being 
developed as a potential therapeutic, information concerning its ef-
fective range is proprietary. We therefore directly assayed SPK-601 
as a PC-PLC inhibitor using PC-PLC purified from Bacillus cereus 
(see Materials and Methods). SPK-601 inhibited PC-PLC in vitro, 
with a dose–response curve and IC50 similar to those of D609 (Figure 
5A). Further, in agreement with the data obtained with D609, SPK-
601 also inhibited production of DAG and PA in vivo in response to 
wounding (Figure 5B), as well as of the activation of Rho and Cdc42 
around wounds (Figure 5C).
responsible for this phenotype, we treated cells with FIPI to reduce 
PA levels independently of DAG. However, FIPI treatment had no 
significant effect on Rho activation and stimulated Cdc42 activation 
in response to wounding (Figure 4, A and C), showing that DAG, 
rather than PA, is essential for Rho and Cdc42 activation after 
wounding. Further, treatment with U-73122, which up-regulates 
DAG (see earlier discussion), also increases levels of active Rho and 
active Cdc42 (Supplemental Figure S2, A and C), whereas propra-
nolol, which does not affect DAG levels, did not affect Rho and 
Cdc42 (Supplemental Figure S2, B and D).
To further assess the role of DAG in the wound response, 
we sought a second means to inhibit PC-PLC. Unfortunately, no 
FIGURE 3: DAG is generated via the PC-PLC/SMS pathway, whereas PA is generated via PLD and DAG kinase. (A) DAG 
is present at wounds in control cells but blocked by the PC-PLC/SMS inhibitor D609. (A′) Quantification of wound DAG 
(***p < 0.005). (B) DAG is present at similar levels at wounds in control cells and those treated with FIPI, a PLD inhibitor. 
(B′) Quantification of wound DAG (p > 0.05). (C) DAG at wounds is elevated in cells treated with the PIP2-PLC inhibitor 
U-73122. (C′) Quantification of wound DAG (***p < 0.005). (D) PA is decreased in cells treated with D609 relative to 
controls. (D′) Quantification of wound PA (*p < 0.05). (E) PA wound signal is blocked in cells treated with FIPI. 
(E′) Quantification of wound PA (***p < 0.005). (F) PA levels at wounds are decreased in cells treated with R59949, a 
DAG kinase inhibitor. (F′) Quantification of wound PA (**p < 0.01). (G) Schematic of pathways leading to DAG and PA 
generation and corresponding inhibitors. Top and bottom whiskers represent maximum and minimum values, 
respectively. Scale bar, 20 μm.
1872 | E. M. Vaughan et al. Molecular Biology of the Cell
DAG is required for healing
The foregoing results indicate that sup-
pression of DAG generation reduces heal-
ing over the course of the first few minutes 
after wounding. To determine whether 
suppression of DAG production affects 
healing of single cell wounds over a longer 
time course, we used the stab wound as-
say (Clark et al., 2012). In this assay, oo-
cytes are stab wounded with glass needles 
in the presence of putative inhibitors or di-
methyl sulfoxide (DMSO), the vehicle, and 
then allowed to heal overnight. Cells that 
heal successfully are intact to the following 
day; those that do not, lyse. At concentra-
tions sufficient to suppress DAG produc-
tion in vivo, both SPK-601 and D609 
sharply impaired healing in this assay rela-
tive to the DMSO controls (Figure 6A). Nei-
ther of these agents, however, caused lysis 
after overnight treatment in the absence of 
wounding, even when applied at 400 μM 
(unpublished data). Of importance, signifi-
cant healing failure was evident at the 
same concentrations required to signifi-
cantly suppress production of DAG around 
wounds (Figure 6B).
FIGURE 4: Blocking generation of DAG, but not PA, inhibits Rho and Cdc42 activation. (A) Cells were injected with 
eGFP-rGBD and mRFP-wGBD to detect active Rho and active Cdc42, respectively. In cells treated with D609, Rho and 
Cdc42 activity is inhibited and wound healing stalls, whereas FIPI treatment does not inhibit GTPase activity or healing. 
(B) Intensity of Rho and Cdc42 zones from control and D609-treated cells was quantified at 60 s (Rho: control vs. D609, 
p < 0.01; Cdc42: control vs. D609, p < 0.005). (C) Intensity of Rho and Cdc42 zones from control and FIPI-treated cells 
was quantified at 60 s (Rho: control vs. FIPI, p >0.05; Cdc42: control vs. FIPI, p < 0.01). Top and bottom whiskers 
represent maximum and minimum values, respectively. Scale bar, 20 μm.
FIGURE 5: SPK601 inhibits PC-PLC, DAG production, and Rho and Cdc42 activation. (A) SPK601 
(SPK) is as an effective inhibitor of PC-PLC in vitro as D609. Lipase activity of purified PC-PLC 
was assayed at the indicated concentrations of each inhibitor. (B) SPK601 suppresses DAG 
production around wounds. (B′) Quantification of wound DAG (p < 0.005). (C) SPK601 
suppresses PA production around wounds. (C′) Quantification of wound PA (p < 0.005). 
(D) SPK601 suppresses Rho and Cdc42 activation around wounds. Intensity of Rho and Cdc42 
zones from control and SPK601-treated cells was quantified at 60 s (Rho: control vs. SPK601, 
p < 0.005; Cdc42: control vs. SPK601, p < 0.005). Top and bottom whiskers represent maximum 
and minimum values, respectively. Scale bar, 20 μm.
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PKCη inhibited Rho and Cdc42 activation (Figure 7, C and F), as did 
overexpression of PKCδ (Supplemental Figure S3G). Curiously, in 
∼20% of the cells overexpressing PKCη, the reduced Rho zone was 
displaced outside the Cdc42 zone (Supplemental Figure S3H). In 
keeping with its apparent role as an inhibitor of Rho and Cdc42, 
expression of DN PKCη significantly up-regulated Rho and Cdc42 
activation at the cortex (Figure 7, C and G). These results suggest 
that PKCβ positively regulates the Rho GTPases, whereas PKCη and 
δ negatively regulate them. Consistent with this notion, simultane-
ous overexpression of PKCη and expression of DN PKCβ almost 
completely suppressed Rho and Cdc42 activation in response to 
wounding (Figure 5, C and H). Thus two different classes of PKC—
conventional and novel—play apparently antagonistic roles in 
wound repair.
DISCUSSION
The results presented here provide what is, to the best of our knowl-
edge, the first demonstration of a role for a specific lipid—DAG—in 
the single-cell wound response. DAG may function indirectly by sig-
naling to Rho and Cdc42 (e.g., Yu and Bement, 2007). However, in 
addition to PKC activation, DAG promotes membrane fusion (e.g., 
Zick et al., 2014), an obvious means for this lipid to promote the 
repair response. The concentration of DAG around wounds, as well 
as its role in the healing response in vivo, suggests that in vitro 
behavior of putative protein players in the healing process should 
be analyzed under conditions in which DAG is included in the rele-
vant assays. It also follows from the results that manipulations that 
increase DAG production or mimic DAG should be considered as 
potential therapies for pathologies resulting from compromised 
wound repair.
More generally, the discovery of multiple distinct lipid domains 
around wounds, each with a characteristic spatial and temporal pat-
tern of accumulation, supports the idea that cells can organize 
plasma membrane lipids as signaling platforms. However, the diver-
sity of such domains seen here goes far beyond any other example 
in the literature, and the micrometer scale of the domains greatly 
exceeds the hypothesized nanometer scale of lipid rafts (Owen 
et al., 2012). However, our results are consistent with recent work in 
demonstrating micrometer-scale domains enriched with sphin-
gosine (Frisz et al., 2013a,b; for review, see Kraft, 2013).
Although we focused on DAG in this work, largely due to the 
timing of its accumulation at wounds, this should not be taken to 
imply that the other lipids are not involved in the repair process. We 
think it likely that most or all of them play roles in the developing 
wound array, although the roles may be subtle. The concentration of 
acidic phospholipids in the regions overlapping the Rho and Cdc42 
zones, for example, may help maintain these zones, in that such 
lipids are believed to promote the liberation of Rho GTPases from 
GDP dissociation inhibitor (e.g., Fauré et al., 1999).
In no case did we observe complete recovery of normal plasma 
membrane lipid distribution within at least 3 min of wounding. 
This contrasts with the oft-stated expectation that repair of the 
plasma membrane takes place within seconds of damage but is 
consistent with recent results obtained using a generic membrane 
marker in Drosophila syncytial embryos (Abreu-Blanco et al., 2011). 
Thus it might be useful to draw a distinction between the point at 
which the plasma membrane hole is sealed and the point at which 
the plasma membrane has completely regenerated. Further, given 
the recent demonstration that plasma membrane wounds in cul-
tured cells can be open for >1 min (Jimenez et al., 2014), the as-
sumption that resealing occurs within seconds may need to be 
reevaluated.
PKCβ and PKCη differentially regulate Rho and Cdc42 zones
On the basis of the foregoing results, on previous studies indicating 
that the PKCs—well-known DAG targets—participate in the single-
cell wound response (Bement and Capco, 1991; Togo et al., 1999), 
and on evidence that the PKCs participate in Rho GTPase activation 
in Xenopus eggs (Yu and Bement, 2007), we investigated the local-
ization of different Xenopus PKCs after wounding. PKCβ, a conven-
tional PKC regulated by binding to calcium and DAG (Newton, 
1997), is rapidly recruited to a region that encompasses both the 
Rho (unpublished data) and the Cdc42 zones (Figure 7A and Sup-
plemental Figure S3, A–A′). PKCη and δ, novel PKCs regulated by 
DAG but not calcium binding, are also rapidly recruited to wounds 
but in a much narrower domain, corresponding to the region of 
DAG synthesis (Figure 7A and Supplemental Figure S3, B–B′ and 
C–C′). In contrast, PKCλ, which does not bind DAG, fails to localize 
to wounds (Supplemental Figure S3D). Further, inhibition of DAG 
generation with D609 significantly reduces the localization of PKCη 
and PKCβ to the wound (Supplemental Figure S3, E and F). Thus 
DAG-dependent PKC isoforms are rapidly targeted to wounds in a 
DAG-dependent manner.
Potential roles for the PKCs in the wound response were as-
sessed by overexpressing PKCβ or PKCη or expressing dominant-
negative (DN) versions of these proteins. PKCβ overexpression sig-
nificantly upregulated wound-induced Rho and Cdc42 activation, 
whereas expression of DN PKCβ significantly down-regulated Rho 
and Cdc42 activation (Figure 7, C– E). In contrast, overexpression of 
FIGURE 6: Dose-dependent suppression of healing and DAG 
production by SPK601 or D609. (A) Cells were treated with DMSO, 
the vehicle, or the indicated micromolar concentrations of SPK601 (S) 
or D609 (D) for 1 h, stab wounded with a glass needle, cultured 
overnight, and then assessed for survival. SPK601 and D609 both 
significantly suppressed healing at concentrations of 100 or 200 μM. 
(B) Quantification of wound DAG levels in cells treated as in A. Bars, 
mean ± SD; *p < 0.05; ***p < 0.005.
1874 | E. M. Vaughan et al. Molecular Biology of the Cell
FIGURE 7: PKCβ and PKCη differentially regulate Rho and Cdc42 zones. (A) Cells injected with PKCβ -eGFP and 
PKCη-mCherry reveal localization of both PKCs to the wound edge, with PKCβ spanning a broader region than PKCη. 
(B) A line scan from the 90-s time point of A. (C) Cells were injected with eGFP-rGBD and mRFP-wGBD alone or with 
PKCβ, DN PKCβ, PKCη, DN PKCη, or DN PKCβ and PKCη. PKCβ up-regulates Rho and Cdc42 activity zones, whereas 
DN PKCβ down-regulates zones. PKCη inhibits Rho and Cdc42 activity zones, whereas DN PKCβ up-regulates Rho and 
Cdc42 activity on the cortex. Expression of DN PKCβ and full-length PKCη results in dramatic inhibition of both Rho and 
Cdc42 activity zones. (D) Quantification of Rho and Cdc42 zone intensity at 30 and 60 s with PKCβ expression (control, 
n = 6; PKCβ, n = 7). (E) Quantification of Rho and Cdc42 zone intensity at 60 s and background intensity with DN PKCβ 
expression (control, n = 16; PKCβ DN, n = 11). (F) Quantification of Rho and Cdc42 zone intensity at 30 and 60 s with 
PKCη expression (n = 14). (G) Quantification of Rho and Cdc42 zone intensity at 60 s and background intensity with DN 
PKCη expression (control, n = 16; PKCη DN, n = 11). (H) Quantification of Rho and Cdc42 zone intensity at 30 and 60 s 
with expression of DN PKCβ and full-length PKCη (control, n = 16, PKCβ DN/PKCη, n = 13). Green bars, Rho; red bars, 
Cdc42. Top and bottom whiskers represent maximum and minimum values, respectively. Scale bar, 20 μm. W, wound.
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C1-domain–containing probes were injected at 500 μg/ml. eGFP-
PH (GRP1) was injected at 600 μg/ml, and mCherry-PH (GRP1) was 
injected at 800 μg/ml. eGFP-PH (PLCδ ) was injected at 50 μg/ml, 
and C2 (Lact)-mCherry was injected at 100 μg/ml. PKCβ-eGFP, 
PKCη-eGFP, and PKCη-mCherry were injected at 500 μg/ml. PKCδ-
eGFP and aPKCλ-eGFP were injected at 1 mg/ml. For overexpres-
sion, PKCβ was injected at 1.5 mg/ml, and PKCη and PKCδ were 
both injected at 2 mg/ml. For DN experiments, PKCη C2-C1 and 
PKCβ C1-C2 mRNAs were polyadenylated using the Poly(A) tailing 
kit (Ambion) and injected at 2 mg/ml. Alexa Fluor 647–G-actin 
(Molecular Probes, Grand Island, NY) was diluted to 1 mg/ml in 
G-Buffer before injection and imaged after 15 min.
Inhibitors
Cells were incubated in 5 μM latrunculin A (Calbiochem, Darmstadt, 
Germany) for 80–120 min. For experiments with D609 (Calbiochem), 
oocytes were washed and incubated in 1× Barth’s at pH 6.9, with 
10 mM 1,4-piperazinediethanesulfonic acid in place of 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid. From 100 to 
200 μM D609 or SPK601 (1% DMSO for control) was added to cells 
30–75 min before wounding. FIPI hydrochloride hydrate, 1 μM 
(Sigma-Aldrich; 0.1% DMSO for control), was added to cells 
20–45 min before wounding. U-73122, 1 μM (Calbiochem; 0.1% 
EtOH for control), was added to cells 5–30 min before wounding. 
(R)-(±)-Propranolol hydrochloride, 400 μM (Calbiochem; 0.08% 
MeOH for control), was added to cells 5–10 min before wounding. 
R59949, 100 μM (Calbiochem; 1% DMSO for control), was added 
to cells 60–90 min before wounding.
For quantification of D609 and SPK-601 inhibition of PC-PLC in 
vitro, 150 mU/ml B. cereus PC-PLC was purified and preincubated 
with the inhibitors for 5 min before starting the LIPASE reaction 
(purchased from Invitrogen). Reactions were run for 60 min in pres-
ence of fluorescent PLC substrate, and PLC activity was monitored 
by measuring fluorescence of the reaction product at 492/520 nm.
For the long-term wounding assay, oocytes were preincubated 
in the indicated concentrations of SPK-601 or D609 or, as a con-
trol, DMSO, for 1 h and then stabbed four times with a 30-μm (tip 
width) glass needle and incubated overnight at 17°C. Other con-
trols were maintained in 200–400 μM SPK-601 or D609 overnight 
without wounding. After overnight incubation, oocytes were 
scored for lysis by inspection with a dissecting microscope (Clark 
et al., 2012).
Microscopy and data analysis
Four-dimensional imaging experiments were conducted using an 
Axiovert 100M (Carl Zeiss Microimaging, Thornwood, NY) with 
the Lasersharp Confocal package (model 1024; Bio-Rad) with a 
63× objective. Cells were wounded with a Micropoint pulse nitro-
gen-pumped dye laser (Laser Science, Mumbai, India). Brightest-
point projections, kymographs line scans, and intensity data were 
obtained using ImageJ software (National Institutes of Health, 
Bethesda, MD). Brightest-point projections are z-projections of 
maximum-intensity points from three-dimensional movies. Line 
scans are derived from a 10-pixel-wide line drawn through the 
wound edge, and lines were smoothened by averaging four 
neighbor data points and using a second-order polynomial with 
Prism 5. Distinct lipid domains were characterized by signal peaks 
≥1 μm apart. Zone intensity quantifications were obtained as de-
scribed previously (Vaughan et al., 2011). Data analysis and graph-
ing was conducted with Excel 2004 for Mac (Microsoft) and Prism 
5 for Mac OSX. Statistically significant results correspond to the 
following p values: *p < 0.05, **p < 0.01, ***p < 0.001.
Finally, the results add to the growing body of evidence that the 
single-cell wound response is far more complex and ordered than 
originally believed. In the frog oocyte system, for example, results 
from several different studies point to discrete zones of Rho GTPase 
activity (Benink and Bement, 2005), regions within zones that differ 
in terms of cytoskeleton (Mandato and Bement, 2001), Rho GTPase 
turnover (Burkel et al., 2012), Rho GTPase GEF localization (Vaughan 
et al., 2011; Simon et al., 2013), and now, additional subdivisions 
based on differences in lipid and protein kinase C isoform distribu-
tion. Nor is this likely to be frog oocyte specific, in that recent work 
on Drosophila embryos suggests that in that model, cellular 
damage similarly elicits a highly organized series of signaling and 
cytoskeletal events (Abreu-Blanco et al., 2011, 2014), while other 
basic features of the cell wound response are conserved in budding 
yeast (Kono et al., 2012) and mammalian cells (Lin et al., 2012). How 
does this plasma membrane compartmentalization arise, and what 
purpose does it serve? With respect to the former, we suspect that 
it results from hierarchies of interactive gradients initiated by wound-
ing that collaboratively direct the observed compartmentalization 
(Bement and von Dassow, 2014). With respect to the latter, we think 
it probable that compartmentalization contributes to the character-
istic speed and flexibility of the cellular wound response.
MATERIALS AND METHODS
Plasmids
mRFP-wGBD and enhanced green fluorescent protein (eGFP)–rGBD 
were made as previously described (Benink and Bement, 2005). 
Spo20p51-91 was subcloned into pCS2+–eGFP with BamH1 and 
Cla1. eGFP-PKCη C1 and mRFP-PKCη C1 were made by inserting 
the fragment encoding His167-Cys310 of PKCη with BspE1 and 
Xba1 into eGFP-pCS2+ or mRFP-pCS2+, respectively. eGFP-PH 
(GRP1240-398) was obtained from M. Halloran (University of Wiscon-
sin–Madison, Madison, WI) and subcloned into eGFP-pCS2+ or 
mCherry-pCS2+ with BspE1 and Xho1. eGFP-PH (PLC δ) was 
obtained from T. Meyer (Stanford University, Stanford, CA) and sub-
cloned into the pCS2+ vector. eGFP-C2 (lactadherin [Lact]) was ob-
tained from Haematologic Technologies (Essex Junction, VT) and 
subcloned into pCS2-mCherry with Cla1 and EcoR1. The Xenopus 
laevis PKCβ-pCS2+, PKCβ-eGFP, PKCβ C1-C2 (DN PKCβ), eGFP-
PKCβ C1, and eGFP-PKCβ C1mut constructs were made as described 
(Yu and Bement, 2007). X. laevis PKCη (BC073353) was amplified 
from cDNA and inserted into pCS2+ with BamH1 and Xho1 restric-
tion enzymes and into pCS2+–eGFP and pCS2+–mCherry with 
BstB1 and Xba1 restriction enzymes. The DN PKCη C2-C1 construct 
was created by inserting the region corresponding to amino acids 
1–294 of PKCη into pCS2+ with BamH1 and Xba1 restriction en-
zymes. PKCδ (BC078019) was obtained from Open Biosystems, and 
the coding sequence was inserted into pCS2+ and pCS2+–eGFP 
with Stu1 and Xba1. aPKCλ (Xenopus tropicalis) was obtained from 
N. Papalopulu (University of Manchester, Manchester, United King-
dom) and subcloned into pCS2+–eGFP with Stu1 and Xba1.
Oocyte preparation and injections
Xenopus oocytes were obtained and stored as described (Yu and 
Bement, 2007). Where plasmid DNA was injected, 20 nl was in-
jected into the nucleus 48 h before imaging. eGFP-C2 (Lact) plas-
mid was injected at 100 μg/ml, and eGFP-Spo20 and eGFP-Spo20mut 
were injected at 50 μg/ml. mRNA was transcribed in vitro using 
mMessage mMachine SP6 kit (Ambion, Grand Island, NY). Oocytes 
were injected with 40-nl volume of mRNA 24 h before imaging. 
eGFP-rGBD and mRFP-wGBD were injected at 250 μg/ml needle 
concentration. Spo20-eGFP was injected at 750 μg/ml. All 
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